Jefferies Group LLC Exact Sciences Corp Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Jefferies Group LLC holds 14,000 shares of EXAS stock, worth $849,940. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,000

Holding current value

$849,940

% of portfolio

0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	SELL	$31.97 - $49.37 $488,501 - $754,373	-15,280 Reduced 52.19%	14,000 $454,000
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $447,580 - $691,180	14,000 New	14,000 $455,000
Q1 2022 May 16, 2022	SELL	$57.56 - $82.54 $1.69 Million - $2.42 Million	-29,280 Closed	0 $0
Q4 2021 Sep 21, 2023	BUY	$72.5 - $100.68 $1.6 Million - $2.23 Million	22,101 Added 307.86%	29,280 $2.28 Million
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $1.6 Million - $2.23 Million	22,101 Added 307.86%	29,280 $2.28 Million
Q3 2021 Sep 21, 2023	SELL	$90.24 - $124.05 $4.56 Million - $6.27 Million	-50,578 Reduced 87.57%	7,179 $685,000
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $4.56 Million - $6.27 Million	-50,578 Reduced 87.57%	7,179 $685,000
Q2 2021 Sep 21, 2023	SELL	$93.66 - $139.27 $4.59 Million - $6.83 Million	-49,043 Reduced 45.92%	57,757 $7.18 Million
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $4.59 Million - $6.83 Million	-49,043 Reduced 45.92%	57,757 $7.18 Million
Q1 2021 Sep 21, 2023	BUY	$116.57 - $155.01 $2.5 Million - $3.33 Million	21,482 Added 25.18%	106,800 $14.1 Million
Q1 2021 May 14, 2021	BUY	$116.57 - $155.01 $2.5 Million - $3.33 Million	21,482 Added 25.18%	106,800 $14.1 Million
Q4 2020 Sep 21, 2023	BUY	$99.61 - $142.12 $7.1 Million - $10.1 Million	71,318 Added 509.41%	85,318 $11.3 Million
Q4 2020 Feb 16, 2021	SELL	$99.61 - $142.12 $2.36 Million - $3.37 Million	-23,712 Reduced 21.75%	85,318 $11.3 Million
Q3 2020 Nov 13, 2020	SELL	$72.92 - $102.01 $258,282 - $361,319	-3,542 Reduced 3.15%	109,030 $11.1 Million
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $5.89 Million - $9.8 Million	105,711 Added 1540.75%	112,572 $9.79 Million
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $4.07 Million - $11.2 Million	-107,304 Reduced 93.99%	6,861 $398,000
Q4 2019 Feb 13, 2020	BUY	$77.66 - $99.74 $1.31 Million - $1.68 Million	16,872 Added 17.34%	114,165 $10.6 Million
Q3 2019 Nov 13, 2019	BUY	$90.37 - $122.49 $6.11 Million - $8.28 Million	67,559 Added 227.21%	97,293 $8.79 Million
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $5.03 Million - $6.63 Million	-56,157 Reduced 65.38%	29,734 $3.51 Million
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $5.24 Million - $8.17 Million	84,623 Added 6673.74%	85,891 $7.44 Million
Q4 2018 Feb 14, 2019	SELL	$56.04 - $82.66 $629,441 - $928,437	-11,232 Reduced 89.86%	1,268 $80,000
Q3 2018 Nov 14, 2018	SELL	$48.29 - $80.6 $330,641 - $551,868	-6,847 Reduced 35.39%	12,500 $987,000
Q2 2018 Aug 14, 2018	BUY	$37.84 - $69.96 $732,090 - $1.35 Million	19,347 New	19,347 $1.16 Million
Q1 2018 May 15, 2018	SELL	$39.82 - $57.53 $174,132 - $251,578	-4,373 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$46.49 - $60.51 $203,300 - $264,610	4,373	4,373 $230,000

Others Institutions Holding EXAS

# of Institutions

674

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

Vanguard Group Inc Valley Forge, PA

17.8M
Shares

$1.08 Billion
0.02% of portfolio
Capital World Investors Los Angeles, CA

15.8M
Shares

$962 Million
0.17% of portfolio
Wellington Management Group LLP Boston, MA

14.3M
Shares

$870 Million
0.18% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$733 Million
0.01% of portfolio
State Street Corp Boston, MA

6.68M
Shares

$406 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.7B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account